{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:57Z","timestamp":1793313657481,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.phymed.2024.155937","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T02:13:16Z","timestamp":1723083196000},"page":"155937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES"],"prefix":"10.1016","volume":"134","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-4016","authenticated-orcid":false,"given":"Baotong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-5967","authenticated-orcid":false,"given":"Lingyun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155937_bib0001","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1111\/bjh.17068","article-title":"Dynamic evolution of ponatinib-resistant mutations in BCR-ABL1-positive leukaemias revealed by next-generation sequencing","volume":"191","author":"Chen","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.phymed.2024.155937_bib0002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-0186-y","article-title":"Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification","volume":"5","author":"Chen","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phymed.2024.155937_bib0003","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155937_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107690","article-title":"Target identification and validation of natural products with label-free methodology: a critical review from 2005 to 2020","volume":"216","author":"Dai","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2024.155937_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev-biochem-062917-012837","article-title":"Horizontal cell biology: monitoring global changes of protein Interaction states with the proteome-wide cellular thermal shift assay (CETSA)","volume":"88","author":"Dai","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phymed.2024.155937_bib0006","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41596-020-0310-z","article-title":"Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome","volume":"15","author":"Dziekan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phymed.2024.155937_bib0007","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1039\/D1CC05986F","article-title":"Chemoproteomic profiling reveals celastrol as a potential modulator of cholesterol signaling","volume":"58","author":"Geng","year":"2022","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.phymed.2024.155937_bib0008","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.155937_bib0009","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/acschembio.2c00011","article-title":"Integrated mass spectrometry reveals celastrol as a novel catechol-O-methyltransferase Inhibitor","volume":"17","author":"Guo","year":"2022","journal-title":"ACS. Chem. Biol."},{"key":"10.1016\/j.phymed.2024.155937_bib0010","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ajh.26550","article-title":"Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors","volume":"97","author":"Haddad","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.phymed.2024.155937_bib0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2024.155937_bib0012","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4155\/fmc-2017-0294","article-title":"The polypharmacology of natural products","volume":"10","author":"Ho","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.phymed.2024.155937_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.349431.122","article-title":"DNA repair defects in cancer and therapeutic opportunities","volume":"36","author":"Hopkins","year":"2022","journal-title":"Genes Dev."},{"key":"10.1016\/j.phymed.2024.155937_bib0014","first-page":"15","article-title":"Targeting transcription factor YY1 for cancer treatment: current strategies and future directions","author":"Hosea","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2024.155937_bib0015","article-title":"Systematic identification of celastrol-binding proteins reveals that Shoc2 is inhibited by celastrol","volume":"38","author":"Huang","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.phymed.2024.155937_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2019.05.004","article-title":"A systems pharmacology approach uncovers wogonoside as an angiogenesis inhibitor of triple-negative breast cancer by targeting Hedgehog signaling","volume":"26","author":"Huang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.phymed.2024.155937_bib0017","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.phymed.2024.155937_bib0018","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.critrevonc.2018.05.019","article-title":"Molecular targets of celastrol in cancer: recent trends and advancements","volume":"128","author":"Kashyap","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.phymed.2024.155937_bib0019","article-title":"Natural products for treatment of chronic myeloid leukemia, Anti-cancer Drugs - Nature","author":"Khajapeer","year":"2016","journal-title":"Synthesis Cell"},{"key":"10.1016\/j.phymed.2024.155937_bib0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/ejh.14107","article-title":"BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population","volume":"111","author":"Kockerols","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.phymed.2024.155937_bib0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155937_bib0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2009.09.006","article-title":"Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation","volume":"290","author":"Lu","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155937_bib0023","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2024.155937_bib0024","first-page":"22","article-title":"Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect","volume":"9","author":"Luo","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.phymed.2024.155937_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.10.055","article-title":"HMCES maintains genome integrity by shielding abasic sites in single-strand DNA","volume":"176","author":"Mohni","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155937_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6793957","article-title":"Prooxidative activity of celastrol induces apoptosis, DNA damage, and cell cycle arrest in drug-resistant human colon cancer cells","author":"Moreira","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phymed.2024.155937_bib0027","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","article-title":"BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks","volume":"104","author":"Nowicki","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2024.155937_bib0028","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2024.155937_bib0029","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1006\/bbrc.2001.4985","article-title":"Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair","volume":"284","author":"Oei","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155937_bib0030","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/cncr.35038","article-title":"Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy-the surveillance, epidemiology, and end results database, 2000-2019","volume":"129","author":"Sasaki","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.phymed.2024.155937_bib0031","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/cr.2007.111","article-title":"Regulation of DNA double-strand break repair pathway choice","volume":"18","author":"Shrivastav","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.phymed.2024.155937_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.10.031","article-title":"HMCES functions in the alternative end-joining pathway of the DNA DSB repair during class switch recombination in B cells","volume":"77","author":"Shukla","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2024.155937_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114705","article-title":"A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes","volume":"162","author":"Song","year":"2023","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2024.155937_bib0034","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/med.21788","article-title":"Recent advances in proteome-wide label-free target deconvolution for bioactive small molecules","volume":"41","author":"Sun","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2024.155937_bib0035","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/onc.2012.203","article-title":"Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias","volume":"32","author":"Tobin","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155937_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2024.155937_bib0037","article-title":"Identifying the effect of celastrol against ovarian cancer with network pharmacology and in vitro experiments","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155937_bib0038","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/MCB.00679-09","article-title":"Loss of YY1 impacts the heterochromatic state and meiotic double-strand breaks during mouse spermatogenesis","volume":"29","author":"Wu","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.phymed.2024.155937_bib0039","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41401-023-01167-7","article-title":"Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2024.155937_bib0040","doi-asserted-by":"crossref","first-page":"35381","DOI":"10.1074\/jbc.M109.051532","article-title":"Characterization of celastrol to inhibit hsp90 and cdc37 interaction","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155937_bib0041","first-page":"12","article-title":"Proteome integral solubility alteration (PISA) assay in mammalian cells for deep, high-confidence, and high-throughput target deconvolution","author":"Zhang","year":"2022","journal-title":"Bio Protoc."},{"key":"10.1016\/j.phymed.2024.155937_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154096","article-title":"Quantitative chemical proteomics reveals anti-cancer targets of Celastrol in HCT116 human colon cancer cells","volume":"101","author":"Zhang","year":"2022","journal-title":"Phytomedicine"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324005956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324005956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T16:14:32Z","timestamp":1730909672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324005956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"alternative-id":["S0944711324005956"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155937","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155937"}}